Direct oral anticoagulants-associated bleeding complications in patients with genitourinary cancer and venous thromboembolism: from the COMMAND VTE Registry-2
Direct oral anticoagulants (DOACs) are widely used to treat cancer-associated venous thromboembolism (VTE). However, bleeding complications associated with DOACs remain a major concern, particularly in patients with genitourinary (GU) cancer or those with gastrointestinal (GI) cancer. Current guidelines recommend...